Weight-loss drugs' potential impact on cancer
Research indicates that GLP-1 medications, used for weight loss and managing diabetes, may reduce the risk of certain cancers and improve survival rates, though evidence remains mixed. Studies suggest that decreasing obesity through these drugs could impact cancer development and progression, with some data showing lower cancer incidence and recurrence among users. However, more rigorous clinical trials are needed to confirm these potential benefits and understand the underlying mechanisms.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)